The following is a comparison of the incidence rates of gastrointestinal adverse events with semaglutide at different doses from randomized controlled trials: Serious events and warnings: Rare but serious side effects of semaglutide and dulaglutide are: Pancreatitis (inflammation of the pancreas) Changes in vision (worsening diabetic retinopathy) Gallbladder issues (cholecystitis and cholelithiasis) Injection site reactions (redness, inflammation, infection, and scarring) Severe stomachache Suicidal ideation Excessive burping Mood and behaviour changes Hypoglycemia Allergic or hypersensitivity reaction High risk of aspiration (stomach content entering the respiratory tract) during surgical procedures that require anesthesia or sedation GLP-1 medications are contraindicated for patients with a personal or family history of medullary thyroid carcinoma and MEN 2 syndrome (Multiple endocrine neoplasia type 2 syndrome)

These medications are not appropriate for everyone, and the decision to use them should involve a licensed healthcare provider with full knowledge of your health history and current medications
Women experiencing reduced sexual interest, difficulty with arousal, or desire discrepancy with partners may benefit from PT-141
Our team at Valencia Medical Center will help develop a personalized plan based on individual needs
It has been extensively studied in a number of Phase II and III clinical trials as a potential treatment for a number of conditions, notably cachexia (muscle wasting) and appears to be well tolerated (Dalton et al, 2011)
Sampson CM, Dimet AL, Neelakantan H, et al